BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15337331)

  • 21. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
    Lee SW; Lee JG; Lee BJ; Kim YH
    Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study.
    Sato S; Yamakawa Y; Terashima Y; Ohta H; Asada T
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):584-9. PubMed ID: 16958942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.
    Fagerlund B; Søholm B; Fink-Jensen A; Lublin H; Glenthøj BY
    Clin Neuropharmacol; 2007; 30(1):3-12. PubMed ID: 17272964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of clinically significant depressive symptoms in an epidemiologic sample of community-dwelling elders with milder forms of cognitive impairment in Hong Kong SAR.
    Chan SS; Lam LC; Tam CW; Lui VW; Chan WC; Wong S; Wong A; Tham MK; Ho KS; Chan WM; Chiu HF
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):611-7. PubMed ID: 18041794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression.
    Narushima K; Chan KL; Kosier JT; Robinson RG
    Am J Psychiatry; 2003 Jun; 160(6):1157-62. PubMed ID: 12777275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cognition and depression].
    Vilalta-Franch J; Llinàs-Regla J; López-Pousa S
    Rev Neurol; 1998 Oct; 27(158):581-4. PubMed ID: 9803499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greater depression severity associated with less improvement in depression-associated cognitive deficits in older subjects.
    Taylor WD; Wagner HR; Steffens DC
    Am J Geriatr Psychiatry; 2002; 10(5):632-5. PubMed ID: 12213698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment.
    Nagaraja D; Jayashree S
    Am J Psychiatry; 2001 Sep; 158(9):1517-9. PubMed ID: 11532743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder.
    Hasselbalch BJ; Knorr U; Hasselbalch SG; Gade A; Kessing LV
    Eur Psychiatry; 2013 Aug; 28(6):349-55. PubMed ID: 22944336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study.
    Hvas AM; Juul S; Nexø E; Ellegaard J
    J Intern Med; 2003 Feb; 253(2):146-52. PubMed ID: 12542554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of cognitive and non-cognitive symptoms in cerebrovascular disease].
    Litvinenko IV; Naumov KM; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(4):35-40. PubMed ID: 24874315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive symptoms in late-life depression and their treatment.
    Siegfried K
    J Affect Disord; 1985; Suppl 1():S33-40. PubMed ID: 2936784
    [No Abstract]   [Full Text] [Related]  

  • 36. Depression in an elderly man.
    Ishida Y
    JAMA; 2002 Jun; 287(24):3210; author reply 3210-1. PubMed ID: 12076214
    [No Abstract]   [Full Text] [Related]  

  • 37. Placebos: who's being fooled?
    Knapp DA; Knapp DA; Michocki RJ
    Am Pharm; 1984 Jan; NS24(1):4-5. PubMed ID: 6695720
    [No Abstract]   [Full Text] [Related]  

  • 38. [New improvement of the treatment of hydrocyanic acid poisoning].
    PAULET G
    Presse Med (1893); 1957 Mar; 65(25):573-6. PubMed ID: 13431781
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial.
    Eussen SJ; de Groot LC; Joosten LW; Bloo RJ; Clarke R; Ueland PM; Schneede J; Blom HJ; Hoefnagels WH; van Staveren WA
    Am J Clin Nutr; 2006 Aug; 84(2):361-70. PubMed ID: 16895884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
    Malouf R; Grimley Evans J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004514. PubMed ID: 18843658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.